CROSS Versus FLOT Regimens in Esophageal and Esophagogastric Junction Adenocarcinoma-Reference-Cited by-同舟云学术

CROSS Versus FLOT Regimens in Esophageal and Esophagogastric Junction Adenocarcinoma

Published:2022-07-25 Issue:5 Volume:276 Page:792-798
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Donlon Noel E.,Moran Brendan,Kamilli Anitha,Davern Maria,Sheppard Andrew,King Sinead,Donohoe Claire L.,Lowery Maeve,Cunningham Moya,Ravi Narayanasamy,Mueller Carmen,Cools-Lartigue Jonathan,Ferri Lorenzo,Reynolds John V.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference34 articles.

1. Advances in the curative management of oesophageal cancer;Bolger;Br J Cancer,2021

2. Preoperative chemoradiotherapy for esophageal or junctional cancer;van Hagen;N Engl J Med,2012

3. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer;Cunningham;N Engl J Med,2006

4. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial;Ychou;J Clin Oncol,2011

5. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial;Al-Batran;Lancet,2019

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a novel oncolytic adenovirus controlled by CDX2 promoter for esophageal adenocarcinoma therapy;Journal of Gastroenterology;2024-09-04

2. Insights from explainable AI in oesophageal cancer team decisions;Computers in Biology and Medicine;2024-09

3. Response to Letter to the Editor on “Impact of the Surgical Approach for Neoadjuvantly Treated Gastroesophageal Junction Type II Tumors: A Multinational, High-Volume Center Retrospective Cohort Analysis”;Annals of Surgery Open;2024-08-12

4. Open Gastric Surgery for Gastric Cancer;Surgical Clinics of North America;2024-08

5. Quality performance indicators for oesophageal and gastric cancer: ANZ expert Delphi consensus;ANZ Journal of Surgery;2024-07-28